Home › Companies › JANUX THERAPEUTICS INC. › 2023-2024
At JANUX THERAPEUTICS INC.'s shareholder meeting held June 26, 2024, in the 2023-2024 proxy season, 53 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 700 separate fund positions. On the most widely held item on that ballot — To elect the three nominees for Class III director named in the proxy statement to serve for… — JANUX THERAPEUTICS INC.'s filing reports the nominee as elected, with 86% support of the votes cast (FOR divided by FOR plus WITHHELD, because this ballot offered only for and withhold; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: JANUX THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 28, 2024.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and JANUX THERAPEUTICS INC.’s Form 8-K, filed June 28, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 26, 2024: 4 items on JANUX THERAPEUTICS INC.’s Form 8-K, filed June 28, 2024: 3 elected · 1 approved.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore JANUX THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are JANUX THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 28, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Vickie Capps | 48,034,233 | -- | -- | 98,744 | 1,671,776 | 99.7% | Elected | — |
| Elect Director: Jay Lichter, Ph.D. | 46,352,481 | -- | -- | 1,698,166 | 1,754,106 | 96% | Elected | — |
| Elect Director: Jake Simson, Ph.D. | 41,538,424 | -- | -- | 6,589,319 | 1,677,010 | 86% | Elected | — |
| 2. Ratification of the Selection of Independent Registered Public Accounting Firm | 49,801,743 | 1,682 | 1,328 | -- | -- | 99.9% | Approved | — |
Source: JANUX THERAPEUTICS INC., Form 8-K, filed with the SEC on June 28, 2024 — read the filing on EDGAR.
Each item below shows how the 53 asset managers that disclosed a JANUX THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: To elect the three nominees for Class III director named in the proxy statement to serve for three-year terms until the 2027 Annual Meeting of Stockholders: Jake Simson
JANUX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jake Simson, Ph.D.”): 41,538,424 for, 6,589,319 withheld, per its Form 8-K filed June 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The Company's stockholders elected the three persons listed below as Class III directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resig…”
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 7,337,235 for, 1,307,191 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,634,023 | 0 | 0 | 0 | For |
| Vanguard | 765,886 | 0 | 0 | 0 | For |
| BlackRock | 676,593 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 510,643 | Withhold |
| Lord Abbett | 0 | 0 | 0 | 445,190 | Withhold |
| T. Rowe Price | 97,549 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 76,601 | Withhold |
| Equitable | 28,250 | 0 | 0 | 44,212 | Mixed |
| Charles Schwab | 48,130 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 32,120 | Withhold |
| DRIEHAUS MUTUAL FUNDS | 0 | 0 | 0 | 24,957 | Withhold |
| Victory Capital | 0 | 0 | 0 | 24,704 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 22,875 | 0 | 0 | 0 | For |
| Lincoln Financial | 14,400 | 0 | 0 | 8,000 | Mixed |
| Nushares ETF Trust | 0 | 0 | 0 | 19,932 | Withhold |
| SEI | 0 | 0 | 0 | 19,716 | Withhold |
| Northern Trust | 14,100 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 0 | 0 | 0 | 13,666 | Withhold |
| Nationwide | 0 | 0 | 0 | 11,816 | Withhold |
| Pacific Life | 10,605 | 0 | 0 | 0 | For |
| John Hancock | 3,300 | 0 | 0 | 7,119 | Mixed |
| AIG/SunAmerica | 0 | 0 | 0 | 8,524 | Withhold |
| Global X | 0 | 0 | 0 | 7,432 | Withhold |
| Bridge Builder Trust | 6,844 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 6,559 | Withhold |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Description as filed by funds: To elect the three nominees for Class III director named in the proxy statement to serve for three-year terms until the 2027 Annual Meeting of Stockholders: Jay Lichter
JANUX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jay Lichter, Ph.D.”): 46,352,481 for, 1,698,166 withheld, per its Form 8-K filed June 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The Company's stockholders elected the three persons listed below as Class III directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resig…”
Support: 96% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 7,868,143 for, 776,283 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,625,871 | 0 | 0 | 8,152 | For |
| Vanguard | 765,886 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 676,593 | Withhold |
| JANUS INVESTMENT FUND | 510,643 | 0 | 0 | 0 | For |
| Lord Abbett | 445,190 | 0 | 0 | 0 | For |
| T. Rowe Price | 97,549 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 76,601 | 0 | 0 | 0 | For |
| Equitable | 45,312 | 0 | 0 | 27,150 | Mixed |
| Charles Schwab | 48,130 | 0 | 0 | 0 | For |
| American Century | 32,120 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 24,957 | 0 | 0 | 0 | For |
| Victory Capital | 24,704 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 22,875 | Withhold |
| Lincoln Financial | 8,000 | 0 | 0 | 14,400 | Mixed |
| Nushares ETF Trust | 19,932 | 0 | 0 | 0 | For |
| SEI | 19,716 | 0 | 0 | 0 | For |
| Northern Trust | 14,100 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 13,666 | 0 | 0 | 0 | For |
| Nationwide | 11,816 | 0 | 0 | 0 | For |
| Pacific Life | 3,600 | 0 | 0 | 7,005 | Mixed |
| John Hancock | 10,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 8,524 | 0 | 0 | 0 | For |
| Global X | 7,432 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 0 | 6,844 | Withhold |
| ProShares | 6,559 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.7% Majority: yes · of votes cast
Description as filed by funds: To elect the three nominees for Class III director named in the proxy statement to serve for three-year terms until the 2027 Annual Meeting of Stockholders: Vickie Capps
JANUX THERAPEUTICS INC.’s own tally for this item (“Elect Director: Vickie Capps”): 48,034,233 for, 98,744 withheld, per its Form 8-K filed June 28, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Proposal 1: Election of Directors The Company's stockholders elected the three persons listed below as Class III directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resig…”
Support: 99.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 8,641,318 for, 3,108 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,634,023 | 0 | 0 | 0 | For |
| Vanguard | 765,886 | 0 | 0 | 0 | For |
| BlackRock | 676,593 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 510,643 | 0 | 0 | 0 | For |
| Lord Abbett | 445,190 | 0 | 0 | 0 | For |
| T. Rowe Price | 97,549 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 76,601 | 0 | 0 | 0 | For |
| Equitable | 72,462 | 0 | 0 | 0 | For |
| Charles Schwab | 48,130 | 0 | 0 | 0 | For |
| American Century | 32,120 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 24,957 | 0 | 0 | 0 | For |
| Victory Capital | 24,704 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,875 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,400 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 19,932 | 0 | 0 | 0 | For |
| SEI | 19,716 | 0 | 0 | 0 | For |
| Northern Trust | 14,100 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 13,666 | 0 | 0 | 0 | For |
| Nationwide | 11,816 | 0 | 0 | 0 | For |
| Pacific Life | 10,605 | 0 | 0 | 0 | For |
| John Hancock | 10,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 8,524 | 0 | 0 | 0 | For |
| Global X | 7,432 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,844 | 0 | 0 | 0 | For |
| ProShares | 6,559 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE SELECTION BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2024.
JANUX THERAPEUTICS INC.’s own tally for this item (“2. Ratification of the Selection of Independent Registered Public Accounting Firm”): 49,801,743 for, 1,682 against — passed, per its Form 8-K filed June 28, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal …”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 53 asset managers below reported 8,644,126 for, 300 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,634,023 | 0 | 0 | 0 | For |
| Vanguard | 765,886 | 0 | 0 | 0 | For |
| BlackRock | 676,593 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 510,643 | 0 | 0 | 0 | For |
| Lord Abbett | 445,190 | 0 | 0 | 0 | For |
| T. Rowe Price | 97,549 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 76,601 | 0 | 0 | 0 | For |
| Equitable | 72,462 | 0 | 0 | 0 | For |
| Charles Schwab | 48,130 | 0 | 0 | 0 | For |
| American Century | 32,120 | 0 | 0 | 0 | For |
| DRIEHAUS MUTUAL FUNDS | 24,957 | 0 | 0 | 0 | For |
| Victory Capital | 24,704 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 22,875 | 0 | 0 | 0 | For |
| Lincoln Financial | 22,400 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 19,932 | 0 | 0 | 0 | For |
| SEI | 19,716 | 0 | 0 | 0 | For |
| Northern Trust | 14,100 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 13,666 | 0 | 0 | 0 | For |
| Nationwide | 11,816 | 0 | 0 | 0 | For |
| Pacific Life | 10,605 | 0 | 0 | 0 | For |
| John Hancock | 10,419 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 8,524 | 0 | 0 | 0 | For |
| Global X | 7,432 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 6,844 | 0 | 0 | 0 | For |
| ProShares | 6,559 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. All 53 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 51,850,667 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 10.87% |
| 2 | Vanguard | 1.48% |
| 3 | BlackRock | 1.30% |
| 4 | JANUS INVESTMENT FUND | 0.98% |
| 5 | Lord Abbett | 0.86% |
| 6 | T. Rowe Price | 0.19% |
| 7 | Delaware/Macquarie | 0.15% |
| 8 | Equitable | 0.14% |
| 9 | Charles Schwab | 0.09% |
| 10 | American Century | 0.06% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| RA Capital Management, L.P. | — | 13D |
| Jay Lichter, Ph.D. | — | DEF14A |
| Entities affiliated with Avalon Ventures XI, L.P. | — | DEF14A |
| Entities affiliated with RA Capital Healthcare Fund, L.P. | — | DEF14A |
| FMR (Fidelity) | — | 13F |
| FMR LLC | — | DEF14A |
| JANUS HENDERSON GROUP PLC | — | 13G |
| Entities affiliated with BVF Inc. | — | DEF14A |
| BlackRock | — | 13F |
| Paradigm BioCapital Advisors LP | — | 13G |
Percentages above are of 51,850,667 shares outstanding, as reported by JANUX THERAPEUTICS INC. on its Form 10-Q dated May 3, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from JANUX THERAPEUTICS INC.’s 10-Q dated May 3, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
JANUX THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
proxyvotesnow.com, “JANUX THERAPEUTICS (JANX) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/janux-therapeutics-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.